Trinity College Dublin | Date: 2017-06-21
A method for making a porous devitalised scaffold suitable for use in repair of osseous, chondral, or osteochondral defects in a mammal comprises the steps of providing micronized extracellular matrix (ECM) tissue, mixing the micronized extracellular matrix with a liquid to provide a slurry, and freeze-drying the slurry to provide the porous scaffold. A porous scaffold suitable for use in repair of osseous, chondral, or osteochondral defects in a mammal and comprising a porous freeze-dried matrix formed from micronised decellularised extracellular matrix tissue is also described.
Trinity College Dublin and University College Dublin | Date: 2017-07-05
A seed coating composition comprising a mixture of a fungal root endophyte isolated from a root of the plant found in low-nutrient, drought-stressed or multiply-stressed conditions and a carrier medium for application of said composition to a target seed, wherein the endophyte is characterised in having a nuclear ribosomal internal transcribed spacer (nr ITS) with at least a 90% sequence identity to any one of SEQ ID NOs: 3 to 15.
Trinity College Dublin | Date: 2017-07-05
This invention relates to methods and kit for the diagnosis, identification and/or staging of cancer, preferably carcinoma or adenocarcinoma. Advantageously, the invention also relates to a method and kit for the diagnosis, identification and/or staging of inflamed or malignant intestinal tissue and/or associated disease state. These methods involve the monitoring and/or detecting of the level of expression of caspase proteins in a sample to assess a deviation in the caspase protein expression levels to provide a diagnosis. The invention also relates to methods for the treatment of cancer in a subject.
Trinity College Dublin | Date: 2017-01-18
The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
Trinity College Dublin | Date: 2017-02-01
This invention relates to 3-phenyl-7-hydroxy-isocoumarin compounds which are MIF inhibitors, compositions comprising said inhibitors and methods for treating or preventing diseases associated with MIF.
Trinity College Dublin | Date: 2017-01-25
The present invention relates to Toll-Like Receptor 2 (TLR2) agonists, in particular, to TLR2-activating lipoproteins, and more particularly to TLR2-activating lipopeptides derived from the bacteria Bordetella pertussis. The invention further extends to the use of said TLR2-activating lipoproteins as a therapeutic or as part of a vaccine composition in the treatment and prevention of infectious diseases, cancer or allergic diseases.
Trinity College Dublin and InvivoGen SAS | Date: 2017-05-24
A compound of formula (I) or a pharmaceutically acceptable derivative thereof, (formula 1) wherein R1,R2, R3, R4, R5, X, m and n are defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
Trinity College Dublin and University College Cork | Date: 2017-04-12
A poly(methyl methacrylate) (PMMA) membrane having a highly porous, reticulated, 3-D structure suitable for lateral flow diagnostic applications is described. Also described is a method for producing a poly(methyl methacrylate) (PMMA) membrane that comprises the steps of mixing a suitable amount of PMMA, a solvent and a optionally one of either a co-solvent or a non-solvent to produce a solution, casting a thin film of the solution onto a support, and removal of the solvent from the solution to produce the PMMA membrane. A lateral flow diagnostic device comprising a highly porous PMMA membrane as a reaction membrane is also described
Cunningham C.,Trinity College Dublin
GLIA | Year: 2013
It is well accepted that CNS inflammation has a role in the progression of chronic neurodegenerative disease, although the mechanisms through which this occurs are still unclear. The inflammatory response during most chronic neurodegenerative disease is dominated by the microglia and mechanisms by which these cells contribute to neuronal damage and degeneration are the subject of intense study. More recently it has emerged that systemic inflammation has a significant role to play in the progression of these diseases. Well-described adaptive pathways exist to transduce systemic inflammatory signals to the brain, but activation of these pathways appears to be deleterious to the brain if the acute insult is sufficiently robust, as in severe sepsis, or sufficiently prolonged, as in repeated stimulation with robust doses of inflammogens such as lipopolysaccharide (LPS). Significantly, moderate doses of inflammogens produce new pathology in the brain and exacerbate or accelerate features of disease when superimposed upon existing pathology or in the context of genetic predisposition. It is now apparent in multiple chronic disease states, and in ageing, that microglia are primed by prior pathology, or by genetic predisposition, to respond more vigorously to subsequent inflammatory stimulation, thus transforming an adaptive CNS inflammatory response to systemic inflammation, into one that has deleterious consequences for the individual. In this review, the preclinical and clinical evidence supporting a significant role for systemic inflammation in chronic neurodegenerative diseases will be discussed. Mechanisms by which microglia might effect neuronal damage and dysfunction, as a consequence of systemic stimulation, will be highlighted. © 2012 Wiley Periodicals, Inc.
Coleman J.N.,Trinity College Dublin
Accounts of Chemical Research | Year: 2013
Due to its unprecedented physical properties, graphene has generated huge interest over the last 7 years. Graphene is generally fabricated in one of two ways: as very high quality sheets produced in limited quantities by micromechanical cleavage or vapor growth or as a rather defective, graphene-like material, graphene oxide, produced in large quantities. However, a growing number of applications would profit from the availability of a method to produce high-quality graphene in large quantities.This Account describes recent work to develop such a processing route inspired by previous theoretical and experimental studies on the solvent dispersion of carbon nanotubes. That work had shown that nanotubes could be effectively dispersed in solvents whose surface energy matched that of the nanotubes. We describe the application of the same approach to the exfoliation of graphite to give graphene in a range of solvents. When graphite powder is exposed to ultrasonication in the presence of a suitable solvent, the powder fragments into nanosheets, which are stabilized against aggregation by the solvent. The enthalpy of mixing is minimized for solvents with surface energies close to that of graphene (∼68 mJ/m 2). The exfoliated nanosheets are free of defects and oxides and can be produced in large quantities. Once solvent exfoliation is possible, the process can be optimized and the nanosheets can be separated by size. The use of surfactants can also stabilize exfoliated graphene in water, where the ζ potential of the surfactant-coated graphene nanosheets controls the dispersed concentration.Liquid exfoliated graphene can be used for a range of applications: graphene dispersions as optical limiters, films of graphene flakes as transparent conductors or sensors, and exfoliated graphene as a mechanical reinforcement for polymer-based composites. Finally, we have extended this process to exfoliate other layered compounds such as BN and MoS2. Such materials will be important in a range of applications from thermoelectrics to battery electrodes. This liquid exfoliation technique can be applied to a wide range of materials and has the potential to be scaled up into an industrial process. We believe the coming decade will see an explosion in the applications involving liquid exfoliated two-dimensional materials. © 2012 American Chemical Society.